David Mathes
Concepts (361)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammaplasty | 36 | 2024 | 99 | 10.270 |
Why?
| Perforator Flap | 13 | 2024 | 34 | 5.350 |
Why?
| Vascularized Composite Allotransplantation | 5 | 2024 | 32 | 3.320 |
Why?
| Surgical Flaps | 12 | 2024 | 146 | 3.210 |
Why?
| Transplantation Tolerance | 9 | 2024 | 34 | 2.760 |
Why?
| Surgery, Plastic | 7 | 2024 | 35 | 2.650 |
Why?
| Graft Survival | 16 | 2024 | 505 | 2.460 |
Why?
| Graft Rejection | 14 | 2024 | 558 | 2.320 |
Why?
| Epigastric Arteries | 14 | 2024 | 24 | 2.200 |
Why?
| Rectus Abdominis | 5 | 2024 | 16 | 1.960 |
Why?
| Skin Transplantation | 9 | 2018 | 88 | 1.790 |
Why?
| Free Tissue Flaps | 5 | 2024 | 53 | 1.730 |
Why?
| Microsurgery | 10 | 2024 | 70 | 1.710 |
Why?
| Myocutaneous Flap | 3 | 2024 | 11 | 1.610 |
Why?
| Composite Tissue Allografts | 4 | 2016 | 8 | 1.580 |
Why?
| Facial Transplantation | 5 | 2014 | 10 | 1.570 |
Why?
| Breast Implants | 5 | 2024 | 20 | 1.470 |
Why?
| Hand Transplantation | 5 | 2011 | 9 | 1.410 |
Why?
| Breast Neoplasms | 15 | 2024 | 2150 | 1.400 |
Why?
| Postoperative Complications | 17 | 2024 | 2496 | 1.270 |
Why?
| Surgical Wound Dehiscence | 4 | 2024 | 22 | 1.210 |
Why?
| Breast Implantation | 4 | 2024 | 13 | 1.180 |
Why?
| Immune Tolerance | 8 | 2024 | 349 | 1.180 |
Why?
| Transplantation Chimera | 6 | 2014 | 54 | 1.140 |
Why?
| Bone Marrow Transplantation | 6 | 2014 | 268 | 1.110 |
Why?
| Acellular Dermis | 3 | 2022 | 12 | 1.050 |
Why?
| Transplantation, Homologous | 14 | 2016 | 396 | 1.030 |
Why?
| Fat Necrosis | 2 | 2022 | 7 | 0.960 |
Why?
| Angiography | 5 | 2022 | 192 | 0.930 |
Why?
| Immunosuppressive Agents | 8 | 2024 | 690 | 0.920 |
Why?
| Iliac Artery | 1 | 2024 | 54 | 0.900 |
Why?
| Body Dysmorphic Disorders | 1 | 2023 | 11 | 0.870 |
Why?
| Rhinoplasty | 1 | 2023 | 27 | 0.840 |
Why?
| Preoperative Care | 5 | 2012 | 342 | 0.830 |
Why?
| Breast | 4 | 2024 | 153 | 0.830 |
Why?
| Immunotoxins | 4 | 2025 | 51 | 0.820 |
Why?
| Enoxaparin | 1 | 2023 | 59 | 0.820 |
Why?
| Venous Thromboembolism | 2 | 2023 | 275 | 0.800 |
Why?
| Vascular Surgical Procedures | 2 | 2019 | 294 | 0.790 |
Why?
| Surgical Wound Infection | 7 | 2024 | 282 | 0.790 |
Why?
| Transplant Donor Site | 1 | 2021 | 5 | 0.760 |
Why?
| Subcutaneous Tissue | 1 | 2021 | 22 | 0.750 |
Why?
| Retrospective Studies | 31 | 2025 | 14571 | 0.750 |
Why?
| Hematopoietic Stem Cell Transplantation | 3 | 2016 | 574 | 0.740 |
Why?
| Pressure Ulcer | 2 | 2011 | 35 | 0.710 |
Why?
| Abdominal Wall | 2 | 2010 | 23 | 0.660 |
Why?
| Anticoagulants | 2 | 2023 | 614 | 0.650 |
Why?
| Humans | 81 | 2025 | 129116 | 0.650 |
Why?
| Diphtheria Toxin | 4 | 2025 | 61 | 0.630 |
Why?
| Mastectomy | 7 | 2024 | 131 | 0.620 |
Why?
| Kidney Transplantation | 5 | 2012 | 605 | 0.620 |
Why?
| Tissue Transplantation | 3 | 2012 | 11 | 0.610 |
Why?
| Nipples | 1 | 2018 | 8 | 0.590 |
Why?
| Swine | 11 | 2024 | 745 | 0.590 |
Why?
| Models, Animal | 4 | 2024 | 367 | 0.560 |
Why?
| Hematopoietic Stem Cell Mobilization | 1 | 2016 | 22 | 0.540 |
Why?
| Tomography, X-Ray Computed | 3 | 2012 | 2541 | 0.540 |
Why?
| Tissue and Organ Harvesting | 2 | 2014 | 73 | 0.520 |
Why?
| Patient Safety | 1 | 2019 | 291 | 0.510 |
Why?
| Female | 48 | 2025 | 68510 | 0.510 |
Why?
| Bone Marrow Cells | 1 | 2016 | 294 | 0.500 |
Why?
| Practice Patterns, Physicians' | 3 | 2023 | 1269 | 0.470 |
Why?
| Groin | 1 | 2014 | 10 | 0.460 |
Why?
| Perineum | 1 | 2014 | 26 | 0.460 |
Why?
| Pregnancy, Animal | 1 | 2014 | 52 | 0.450 |
Why?
| Negative-Pressure Wound Therapy | 2 | 2024 | 21 | 0.450 |
Why?
| Patient Satisfaction | 3 | 2024 | 647 | 0.450 |
Why?
| Treatment Outcome | 17 | 2024 | 10226 | 0.450 |
Why?
| Laser-Doppler Flowmetry | 1 | 2014 | 34 | 0.450 |
Why?
| Swine, Miniature | 8 | 2024 | 78 | 0.430 |
Why?
| Interleukin-2 | 4 | 2024 | 431 | 0.430 |
Why?
| Pelvis | 1 | 2014 | 102 | 0.430 |
Why?
| Middle Aged | 24 | 2024 | 31074 | 0.430 |
Why?
| Dogs | 5 | 2016 | 366 | 0.420 |
Why?
| Facial Injuries | 2 | 2009 | 18 | 0.400 |
Why?
| Face | 2 | 2013 | 167 | 0.390 |
Why?
| Bone Transplantation | 2 | 2024 | 108 | 0.380 |
Why?
| Prosthesis-Related Infections | 2 | 2024 | 75 | 0.380 |
Why?
| Lymphoma, T-Cell, Cutaneous | 2 | 2023 | 42 | 0.370 |
Why?
| Communications Media | 1 | 2011 | 4 | 0.370 |
Why?
| Abdomen | 3 | 2024 | 117 | 0.370 |
Why?
| Attitude of Health Personnel | 2 | 2009 | 1098 | 0.370 |
Why?
| Bariatric Surgery | 2 | 2024 | 192 | 0.360 |
Why?
| Animals | 23 | 2025 | 34600 | 0.360 |
Why?
| Antibiotic Prophylaxis | 1 | 2012 | 95 | 0.360 |
Why?
| Computed Tomography Angiography | 2 | 2022 | 115 | 0.350 |
Why?
| Obesity, Morbid | 2 | 2024 | 238 | 0.350 |
Why?
| Adult | 23 | 2024 | 35510 | 0.350 |
Why?
| Coitus | 1 | 2010 | 25 | 0.340 |
Why?
| Ultrasonography, Doppler, Duplex | 1 | 2010 | 43 | 0.340 |
Why?
| Ultrasonography, Doppler | 1 | 2010 | 122 | 0.330 |
Why?
| Osteomyelitis | 1 | 2011 | 124 | 0.330 |
Why?
| Body Mass Index | 3 | 2024 | 2266 | 0.330 |
Why?
| Internet | 2 | 2011 | 620 | 0.320 |
Why?
| Follow-Up Studies | 9 | 2024 | 4915 | 0.320 |
Why?
| Traumatology | 1 | 2009 | 25 | 0.320 |
Why?
| Amputation, Traumatic | 1 | 2009 | 21 | 0.310 |
Why?
| Arteries | 2 | 2013 | 267 | 0.310 |
Why?
| Length of Stay | 3 | 2024 | 1123 | 0.310 |
Why?
| Hand Injuries | 1 | 2009 | 36 | 0.310 |
Why?
| Suture Techniques | 2 | 2024 | 121 | 0.300 |
Why?
| Magnetic Resonance Angiography | 1 | 2010 | 237 | 0.300 |
Why?
| Vagina | 1 | 2010 | 176 | 0.290 |
Why?
| Dermatologic Surgical Procedures | 1 | 2008 | 19 | 0.290 |
Why?
| Thigh | 1 | 2008 | 55 | 0.290 |
Why?
| Wounds and Injuries | 2 | 2012 | 719 | 0.280 |
Why?
| Mastectomy, Segmental | 2 | 2017 | 85 | 0.280 |
Why?
| Skin Neoplasms | 3 | 2023 | 833 | 0.280 |
Why?
| Sternum | 2 | 2024 | 25 | 0.280 |
Why?
| Sternotomy | 2 | 2024 | 24 | 0.270 |
Why?
| Back | 1 | 2006 | 11 | 0.270 |
Why?
| Orthopedics | 1 | 2009 | 141 | 0.270 |
Why?
| Cannabis | 2 | 2023 | 436 | 0.270 |
Why?
| United States | 12 | 2025 | 13938 | 0.250 |
Why?
| Histocompatibility | 3 | 2014 | 26 | 0.240 |
Why?
| Societies, Medical | 1 | 2009 | 749 | 0.240 |
Why?
| CD47 Antigen | 1 | 2025 | 27 | 0.240 |
Why?
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 24 | 0.230 |
Why?
| Transplantation Conditioning | 3 | 2016 | 164 | 0.230 |
Why?
| Implant Capsular Contracture | 1 | 2024 | 5 | 0.230 |
Why?
| Reoperation | 4 | 2024 | 560 | 0.230 |
Why?
| Sex Reassignment Surgery | 1 | 2024 | 7 | 0.230 |
Why?
| Cleft Lip | 1 | 2025 | 46 | 0.230 |
Why?
| Physical Therapy Modalities | 2 | 2024 | 294 | 0.230 |
Why?
| Hypertrophy | 1 | 2024 | 115 | 0.230 |
Why?
| Anastomosis, Surgical | 3 | 2020 | 150 | 0.230 |
Why?
| Gender Dysphoria | 1 | 2024 | 19 | 0.230 |
Why?
| Fibula | 1 | 2024 | 49 | 0.220 |
Why?
| Body Contouring | 1 | 2023 | 8 | 0.220 |
Why?
| Fetus | 2 | 2005 | 760 | 0.210 |
Why?
| Mandibular Fractures | 1 | 2023 | 11 | 0.210 |
Why?
| Malocclusion | 1 | 2023 | 25 | 0.210 |
Why?
| Insurance | 1 | 2023 | 12 | 0.210 |
Why?
| Sezary Syndrome | 1 | 2023 | 43 | 0.210 |
Why?
| Skull Fractures | 1 | 2023 | 33 | 0.210 |
Why?
| Head and Neck Neoplasms | 2 | 2022 | 534 | 0.210 |
Why?
| Mycosis Fungoides | 1 | 2023 | 62 | 0.210 |
Why?
| Hindlimb | 2 | 2003 | 125 | 0.210 |
Why?
| Pain, Postoperative | 3 | 2023 | 226 | 0.200 |
Why?
| Seroma | 1 | 2022 | 3 | 0.200 |
Why?
| Weight Loss | 1 | 2008 | 724 | 0.200 |
Why?
| Risk Factors | 7 | 2024 | 9767 | 0.200 |
Why?
| Antineoplastic Agents | 2 | 2024 | 2060 | 0.200 |
Why?
| Extremities | 2 | 2002 | 128 | 0.200 |
Why?
| Educational Measurement | 1 | 2024 | 264 | 0.190 |
Why?
| Clinical Protocols | 1 | 2023 | 254 | 0.190 |
Why?
| Incidental Findings | 1 | 2022 | 80 | 0.190 |
Why?
| Cyclosporine | 3 | 2016 | 169 | 0.180 |
Why?
| Transplantation, Autologous | 3 | 2024 | 215 | 0.180 |
Why?
| Hypotension | 1 | 2022 | 114 | 0.180 |
Why?
| Proteus vulgaris | 1 | 2000 | 1 | 0.180 |
Why?
| Mediastinitis | 1 | 2000 | 3 | 0.180 |
Why?
| Proteus Infections | 1 | 2000 | 5 | 0.180 |
Why?
| Epidermal Growth Factor | 1 | 2021 | 169 | 0.170 |
Why?
| T-Lymphocytes, Regulatory | 2 | 2014 | 376 | 0.170 |
Why?
| Time Factors | 6 | 2014 | 6518 | 0.170 |
Why?
| Flow Cytometry | 4 | 2020 | 1142 | 0.170 |
Why?
| Quality of Life | 3 | 2024 | 2693 | 0.160 |
Why?
| Magnetic Resonance Imaging | 1 | 2011 | 3383 | 0.160 |
Why?
| Blood Vessel Prosthesis | 1 | 2000 | 124 | 0.160 |
Why?
| Keloid | 1 | 2019 | 7 | 0.160 |
Why?
| Dermis | 1 | 2019 | 31 | 0.160 |
Why?
| Antigens | 2 | 2016 | 353 | 0.160 |
Why?
| Aortic Aneurysm, Thoracic | 1 | 2000 | 130 | 0.150 |
Why?
| Analgesics, Opioid | 2 | 2023 | 908 | 0.150 |
Why?
| Postoperative Period | 2 | 2023 | 324 | 0.150 |
Why?
| Incidence | 2 | 2023 | 2635 | 0.150 |
Why?
| Mice, SCID | 3 | 2025 | 347 | 0.150 |
Why?
| Tattooing | 1 | 2018 | 14 | 0.150 |
Why?
| Fluorouracil | 1 | 2019 | 197 | 0.150 |
Why?
| Indocyanine Green | 2 | 2022 | 19 | 0.150 |
Why?
| Internship and Residency | 2 | 2024 | 1061 | 0.140 |
Why?
| Chimera | 2 | 2011 | 59 | 0.140 |
Why?
| Data Collection | 2 | 2011 | 650 | 0.140 |
Why?
| Risk Assessment | 3 | 2024 | 3260 | 0.140 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2017 | 82 | 0.140 |
Why?
| Graft vs Host Disease | 2 | 2016 | 237 | 0.140 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 71 | 0.130 |
Why?
| Imaging, Three-Dimensional | 2 | 2010 | 535 | 0.130 |
Why?
| Bupivacaine | 1 | 2016 | 30 | 0.130 |
Why?
| Hernia, Ventral | 1 | 2016 | 23 | 0.130 |
Why?
| Mycophenolic Acid | 1 | 2016 | 92 | 0.130 |
Why?
| Surveys and Questionnaires | 3 | 2024 | 5376 | 0.130 |
Why?
| Surgical Mesh | 1 | 2016 | 46 | 0.130 |
Why?
| Mental Disorders | 1 | 2024 | 1010 | 0.130 |
Why?
| Herniorrhaphy | 1 | 2016 | 60 | 0.130 |
Why?
| Prospective Studies | 3 | 2021 | 7079 | 0.130 |
Why?
| Opioid-Related Disorders | 1 | 2023 | 494 | 0.120 |
Why?
| Male | 14 | 2025 | 63194 | 0.120 |
Why?
| Muscle, Skeletal | 2 | 2006 | 1640 | 0.120 |
Why?
| Leukocytes | 1 | 2016 | 303 | 0.120 |
Why?
| Xenograft Model Antitumor Assays | 3 | 2025 | 813 | 0.120 |
Why?
| Whole-Body Irradiation | 2 | 2012 | 75 | 0.120 |
Why?
| Lymphocyte Culture Test, Mixed | 1 | 2014 | 48 | 0.120 |
Why?
| Myeloablative Agonists | 1 | 2014 | 21 | 0.120 |
Why?
| Patient Selection | 2 | 2008 | 665 | 0.110 |
Why?
| Cadaver | 2 | 2010 | 330 | 0.110 |
Why?
| False Negative Reactions | 1 | 2014 | 51 | 0.110 |
Why?
| Anti-Bacterial Agents | 1 | 2024 | 1671 | 0.110 |
Why?
| CD3 Complex | 1 | 2014 | 101 | 0.110 |
Why?
| Multivariate Analysis | 3 | 2016 | 1496 | 0.110 |
Why?
| False Positive Reactions | 1 | 2014 | 114 | 0.110 |
Why?
| Dissection | 1 | 2014 | 56 | 0.110 |
Why?
| Temporal Arteries | 1 | 2014 | 46 | 0.110 |
Why?
| Allografts | 1 | 2014 | 137 | 0.110 |
Why?
| Histocompatibility Antigens | 1 | 2014 | 107 | 0.110 |
Why?
| Random Allocation | 1 | 2014 | 346 | 0.110 |
Why?
| Forkhead Transcription Factors | 1 | 2014 | 182 | 0.110 |
Why?
| Prosthesis Failure | 1 | 2014 | 120 | 0.110 |
Why?
| Pain Management | 1 | 2016 | 320 | 0.100 |
Why?
| Reproducibility of Results | 2 | 2021 | 3033 | 0.100 |
Why?
| Health Care Costs | 1 | 2016 | 395 | 0.100 |
Why?
| Multidetector Computed Tomography | 1 | 2013 | 32 | 0.100 |
Why?
| Prostheses and Implants | 1 | 2014 | 138 | 0.100 |
Why?
| Recurrence | 2 | 2019 | 1003 | 0.100 |
Why?
| Receptors, CCR4 | 2 | 2024 | 20 | 0.100 |
Why?
| Telemedicine | 1 | 2021 | 783 | 0.100 |
Why?
| Aged | 7 | 2024 | 22083 | 0.100 |
Why?
| Monitoring, Physiologic | 1 | 2014 | 268 | 0.100 |
Why?
| Regional Blood Flow | 1 | 2014 | 463 | 0.100 |
Why?
| Paternalism | 1 | 2011 | 4 | 0.100 |
Why?
| Collagen | 1 | 2014 | 429 | 0.090 |
Why?
| Beneficence | 1 | 2011 | 17 | 0.090 |
Why?
| Mice | 6 | 2025 | 16644 | 0.090 |
Why?
| Antibodies, Monoclonal | 3 | 2024 | 1359 | 0.090 |
Why?
| Marketing of Health Services | 1 | 2011 | 14 | 0.090 |
Why?
| Hematopoiesis | 1 | 2012 | 185 | 0.090 |
Why?
| Intraoperative Care | 1 | 2011 | 45 | 0.090 |
Why?
| Cell Line, Tumor | 3 | 2025 | 3184 | 0.090 |
Why?
| Mice, Inbred NOD | 2 | 2025 | 584 | 0.090 |
Why?
| Personal Autonomy | 1 | 2011 | 48 | 0.090 |
Why?
| Ethics, Medical | 1 | 2011 | 78 | 0.090 |
Why?
| Professional Practice | 1 | 2011 | 64 | 0.090 |
Why?
| Treatment Failure | 1 | 2012 | 343 | 0.090 |
Why?
| Disease Models, Animal | 3 | 2014 | 3953 | 0.090 |
Why?
| Neovascularization, Physiologic | 1 | 2011 | 172 | 0.090 |
Why?
| Informed Consent | 1 | 2011 | 174 | 0.090 |
Why?
| Ultrasonography, Doppler, Color | 1 | 2010 | 37 | 0.080 |
Why?
| Nutrition Assessment | 1 | 2010 | 85 | 0.080 |
Why?
| Sensitivity and Specificity | 1 | 2014 | 1825 | 0.080 |
Why?
| Radiography, Abdominal | 1 | 2010 | 44 | 0.080 |
Why?
| Practice Guidelines as Topic | 1 | 2017 | 1493 | 0.080 |
Why?
| Logistic Models | 2 | 2016 | 1979 | 0.080 |
Why?
| Organ Transplantation | 1 | 2011 | 219 | 0.080 |
Why?
| North America | 1 | 2009 | 289 | 0.070 |
Why?
| Recombinant Fusion Proteins | 2 | 2021 | 634 | 0.070 |
Why?
| Evidence-Based Medicine | 1 | 2011 | 718 | 0.070 |
Why?
| Health Care Surveys | 1 | 2009 | 558 | 0.070 |
Why?
| Spinal Cord Injuries | 1 | 2010 | 193 | 0.070 |
Why?
| Wound Healing | 2 | 2023 | 311 | 0.070 |
Why?
| Diagnostic Imaging | 1 | 2009 | 330 | 0.070 |
Why?
| Back Injuries | 1 | 2006 | 4 | 0.070 |
Why?
| Omentum | 1 | 2006 | 11 | 0.070 |
Why?
| Case Management | 1 | 2006 | 63 | 0.060 |
Why?
| Cytokines | 1 | 2014 | 1987 | 0.060 |
Why?
| Linear Models | 1 | 2008 | 816 | 0.060 |
Why?
| Debridement | 1 | 2006 | 87 | 0.060 |
Why?
| Neoplasm Recurrence, Local | 1 | 2012 | 963 | 0.060 |
Why?
| Analysis of Variance | 1 | 2008 | 1271 | 0.060 |
Why?
| Burns | 1 | 2009 | 284 | 0.060 |
Why?
| Predictive Value of Tests | 1 | 2010 | 1943 | 0.060 |
Why?
| School Admission Criteria | 1 | 2024 | 23 | 0.060 |
Why?
| Silicone Gels | 1 | 2024 | 4 | 0.060 |
Why?
| Major Histocompatibility Complex | 1 | 2005 | 229 | 0.060 |
Why?
| Licensure, Medical | 1 | 2024 | 14 | 0.060 |
Why?
| Melanoma | 1 | 2012 | 752 | 0.060 |
Why?
| Proof of Concept Study | 1 | 2024 | 65 | 0.060 |
Why?
| Esthetics | 1 | 2024 | 50 | 0.060 |
Why?
| Pectoralis Muscles | 1 | 2024 | 17 | 0.060 |
Why?
| In Vitro Techniques | 1 | 2005 | 1044 | 0.050 |
Why?
| Personnel Selection | 1 | 2024 | 73 | 0.050 |
Why?
| Hydrocodone | 1 | 2023 | 17 | 0.050 |
Why?
| Tobacco Use | 1 | 2023 | 61 | 0.050 |
Why?
| Young Adult | 4 | 2024 | 12389 | 0.050 |
Why?
| Mandible | 1 | 2023 | 64 | 0.050 |
Why?
| Biomarkers | 1 | 2014 | 3896 | 0.050 |
Why?
| Chemoprevention | 1 | 2023 | 90 | 0.050 |
Why?
| Tissue Donors | 1 | 2005 | 388 | 0.050 |
Why?
| Cross-Sectional Studies | 2 | 2024 | 5068 | 0.050 |
Why?
| Physicians | 1 | 2011 | 861 | 0.050 |
Why?
| Insurance Coverage | 1 | 2024 | 222 | 0.050 |
Why?
| Umbilicus | 1 | 2022 | 16 | 0.050 |
Why?
| Transplantation Immunology | 1 | 2002 | 33 | 0.050 |
Why?
| Perfusion | 1 | 2022 | 188 | 0.050 |
Why?
| Pregnancy | 1 | 2014 | 6375 | 0.050 |
Why?
| Peripheral Nerves | 1 | 2002 | 66 | 0.050 |
Why?
| Cicatrix | 1 | 2022 | 58 | 0.050 |
Why?
| Insurance, Health | 1 | 2023 | 271 | 0.050 |
Why?
| Leukocytes, Mononuclear | 1 | 2024 | 538 | 0.050 |
Why?
| Erlotinib Hydrochloride | 1 | 2021 | 68 | 0.050 |
Why?
| Povidone-Iodine | 1 | 2000 | 13 | 0.040 |
Why?
| Musculoskeletal System | 1 | 2001 | 46 | 0.040 |
Why?
| Lymphocyte Depletion | 1 | 2001 | 129 | 0.040 |
Why?
| Therapeutic Irrigation | 1 | 2000 | 76 | 0.040 |
Why?
| Education, Medical, Graduate | 1 | 2024 | 439 | 0.040 |
Why?
| Outpatients | 1 | 2023 | 367 | 0.040 |
Why?
| Students, Medical | 1 | 2024 | 318 | 0.040 |
Why?
| Inhibitory Concentration 50 | 1 | 2020 | 81 | 0.040 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2020 | 76 | 0.040 |
Why?
| Histocompatibility Testing | 1 | 2000 | 120 | 0.040 |
Why?
| Forelimb | 1 | 1999 | 28 | 0.040 |
Why?
| Databases, Factual | 1 | 2025 | 1279 | 0.040 |
Why?
| Dopamine | 1 | 2022 | 285 | 0.040 |
Why?
| ErbB Receptors | 1 | 2022 | 603 | 0.040 |
Why?
| Injections, Intralesional | 1 | 2019 | 34 | 0.040 |
Why?
| Lymphocytes | 1 | 2001 | 369 | 0.040 |
Why?
| Immunity, Cellular | 1 | 2001 | 267 | 0.040 |
Why?
| Tumor Microenvironment | 1 | 2022 | 622 | 0.040 |
Why?
| Chemokine CCL2 | 1 | 2019 | 118 | 0.040 |
Why?
| Tacrolimus | 1 | 1999 | 140 | 0.040 |
Why?
| Medicare | 1 | 2024 | 724 | 0.040 |
Why?
| Veterans | 1 | 2010 | 1419 | 0.040 |
Why?
| Skin | 1 | 2003 | 719 | 0.040 |
Why?
| Margins of Excision | 1 | 2017 | 38 | 0.040 |
Why?
| Carcinoma, Lobular | 1 | 2017 | 48 | 0.030 |
Why?
| Patient Acceptance of Health Care | 1 | 2023 | 767 | 0.030 |
Why?
| Recombinant Proteins | 1 | 2020 | 1284 | 0.030 |
Why?
| Obesity | 2 | 2024 | 2863 | 0.030 |
Why?
| Phosphoproteins | 1 | 2019 | 330 | 0.030 |
Why?
| Narcotics | 1 | 2016 | 47 | 0.030 |
Why?
| Cost Savings | 1 | 2016 | 79 | 0.030 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 391 | 0.030 |
Why?
| Anesthetics, Local | 1 | 2016 | 76 | 0.030 |
Why?
| Nerve Block | 1 | 2016 | 64 | 0.030 |
Why?
| Rats | 1 | 2024 | 5173 | 0.030 |
Why?
| Biopsy | 1 | 2019 | 1086 | 0.030 |
Why?
| Protein Kinase Inhibitors | 1 | 2021 | 872 | 0.030 |
Why?
| Quality Indicators, Health Care | 1 | 2017 | 297 | 0.030 |
Why?
| Tissue Expansion Devices | 1 | 2014 | 5 | 0.030 |
Why?
| Tissue Expansion | 1 | 2014 | 10 | 0.030 |
Why?
| Consensus | 1 | 2017 | 638 | 0.030 |
Why?
| Models, Statistical | 1 | 2018 | 626 | 0.030 |
Why?
| Cellulitis | 1 | 2014 | 47 | 0.030 |
Why?
| Cohort Studies | 1 | 2024 | 5407 | 0.030 |
Why?
| Equipment Failure Analysis | 1 | 2014 | 131 | 0.030 |
Why?
| Cost-Benefit Analysis | 1 | 2016 | 582 | 0.030 |
Why?
| Guideline Adherence | 1 | 2017 | 525 | 0.030 |
Why?
| Leukocyte Transfusion | 1 | 2012 | 2 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2019 | 1689 | 0.020 |
Why?
| Histocompatibility Antigens Class I | 1 | 2012 | 195 | 0.020 |
Why?
| Infant | 1 | 2025 | 8992 | 0.020 |
Why?
| Fluorescence | 1 | 2011 | 158 | 0.020 |
Why?
| Transcription Factors | 1 | 2019 | 1632 | 0.020 |
Why?
| Aged, 80 and over | 2 | 2013 | 7064 | 0.020 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2024 | 2437 | 0.020 |
Why?
| Burns, Electric | 1 | 2009 | 26 | 0.020 |
Why?
| Equipment Design | 1 | 2011 | 518 | 0.020 |
Why?
| Neurofibromatosis 1 | 1 | 2009 | 45 | 0.020 |
Why?
| Comorbidity | 1 | 2014 | 1546 | 0.020 |
Why?
| Feasibility Studies | 1 | 2013 | 862 | 0.020 |
Why?
| Colorado | 1 | 2017 | 4394 | 0.020 |
Why?
| Smoking | 1 | 2014 | 1466 | 0.020 |
Why?
| Wounds, Gunshot | 1 | 2009 | 217 | 0.020 |
Why?
| Diabetes Mellitus | 1 | 2014 | 1004 | 0.020 |
Why?
| Recovery of Function | 1 | 2009 | 648 | 0.020 |
Why?
| Child | 1 | 2024 | 20805 | 0.010 |
Why?
| Coculture Techniques | 1 | 2004 | 225 | 0.010 |
Why?
| Antigens, Surface | 1 | 2001 | 150 | 0.010 |
Why?
| Cells, Cultured | 1 | 2004 | 4010 | 0.010 |
Why?
| T-Lymphocytes | 1 | 2004 | 1924 | 0.010 |
Why?
| Adolescent | 1 | 2012 | 20301 | 0.010 |
Why?
|
|
Mathes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|